Trial Talk: CTLA-winning case validates jury’s role in determining damages
In a rare tie, the Colorado Trial Lawyers Association named Gresser v. Banner Health one of its 2026 Case of the Year honorees this...
SpaceX IPO tests limits of shareholder rights as mega-offerings reshape public markets
The SpaceX initial public offering, expected to be one of the largest in history, is drawing attention not only for its size but for...
Lawsuit challenges predator control in wilderness areas
WildEarth Guardians, Western Watersheds Project and Wilderness Watch filed a lawsuit in the U.S. District Court for the District of New Mexico challenging federal...
Greenberg Traurig adds Space and Government Contracts partner
Greenberg Traurig added Shaun Kennedy as a shareholder in its Denver office, expanding the firm’s government contracts practice. Kennedy joins the firm from Holland...
Man who firebombed demonstration sentenced to life
A judge sentenced a man to life in prison without the possibility of parole Thursday after he pleaded guilty to killing one person and...
5 questions with Jason Spitalnick of Snell & Wilmer
This week's 5Q features Jason Spitalnick, a partner in Snell & Wilmer’s Denver office and a member of the firm’s Litigation, Investigations, and Trials...
Denver defies federal demand to repeal assault weapons ban
Within days of the U.S. Department of Justice ordering Denver to repeal its decades-old assault weapons ban, city officials declined, triggering a direct legal...
Trial Talk: LASIK case tests boundaries of Colorado damages law
In a closely watched medical malpractice case, the District Court for Jefferson County awarded $8.03 million against LASIK provider LASIKPlus in April, raising questions...
State Bill Special Report: Early May activity at the Capitol
State Bill Special Report is a biweekly feature of bills to watch while the Colorado General Assembly is in session and is courtesy of...
Implications for Colorado on federal cannabis reclassification
Following the federal government’s reclassification of state-licensed medical cannabis as a Schedule III substance, lawyers are parsing what the change means in practice, particularly...